Dysentery, Bacillary
Showing 1 - 25 of 48
Shigellosis, Bacillary Dysentery Trial in Leiden (2.5 µg InvaplexAR-Detox, 10 µg InvaplexAR-Detox, 0.1 µg of dmLT)
Not yet recruiting
- Shigellosis
- Bacillary Dysentery
- 2.5 μg InvaplexAR-Detox
- +3 more
-
Leiden, NetherlandsLeiden University Medical Center
Jul 26, 2023
Shigellosis Trial in Dhaka (Tebipenem Pivoxil, Azithromycin, Ceftriaxon)
Recruiting
- Shigellosis
- Tebipenem Pivoxil
- +2 more
-
Dhaka, BangladeshInternational Centre for Diarrhoeal Disease Research, Bangladesh
Jan 18, 2023
Shigellosis Trial in Kilifi (Shigella sonnei 53G, Ciprofloxacin 500 mg)
Not yet recruiting
- Shigellosis
- Shigella sonnei 53G
- Ciprofloxacin 500 mg
-
Kilifi, KenyaKEMRI-Wellcome Trust Research Programme
Jul 17, 2023
Dysentery, Dysentery, Bacillary Trial in Quanzhou (S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine, Haemophilus b Conjugate
Completed
- Dysentery
- Dysentery, Bacillary
- S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine
- Haemophilus b Conjugate Vaccine
-
Quanzhou, Guangxi, ChinaQuanzhou Center for Disease Control and Prevention
Dec 28, 2021
Immunisation, Shigella Infection Trial in Cincinnati (Placebo, Shigella sonnei strain 53G, WRSs2)
Recruiting
- Immunisation
- Shigella Infection
- Placebo
- +2 more
-
Decatur, Georgia
- +1 more
Feb 2, 2023
Support of Clinical Evaluation ofOral Shigella Vaccine
Completed
- Diarrhea
- Diarrhea Infectious
- no intervention
-
Ouagadougou, Burkina Faso
- +2 more
Jul 19, 2022
Shigella Infection, Enterotoxigenic Escherichia Coli Infection Trial in Baltimore (strain CVD 1208S-122, Placebo)
Not yet recruiting
- Shigella Infection
- Enterotoxigenic Escherichia Coli Infection
- strain CVD 1208S-122
- Placebo
-
Baltimore, MarylandUniversity of Maryland, Baltimore, University of Maryland School
Jul 26, 2022
Shigellosis Trial in Kericho, Kilifi (Shigella 4V, MenACWY, Rabies)
Completed
- Shigellosis
- Shigella 4V
- +4 more
-
Kericho, Kenya
- +1 more
Dec 7, 2022
Shigella Trial in Baltimore (SF2a-TT15 Shigella Vaccine, Placebo, S. flexneri 2a strain 2457T Challenge Agent)
Recruiting
- Shigella
- SF2a-TT15 Shigella Vaccine
- +2 more
-
Baltimore, MarylandUniversity of Maryland, Baltimore, Center for Vaccine Developmen
May 5, 2022
Shigellosis Trial in Baltimore (S. sonnei 53G, S. flexneri 2a 2457T)
Recruiting
- Shigellosis
- S. sonnei 53G
- S. flexneri 2a 2457T
-
Baltimore, MarylandCenter for Immunization Research (CIR) at Johns Hopkins School o
Dec 15, 2021
Shigellosis, Bacillary Dysentery Trial in Silver Spring (Shigella flexneri 2a InvaplexAR)
Completed
- Shigellosis
- Bacillary Dysentery
- Shigella flexneri 2a InvaplexAR
-
Silver Spring, MarylandWalter Reed Army Institute of Research, Clinical Trials Center
Feb 10, 2021
Dysentery, Shigellosis Trial in China (S. Flexneriza-S. Sonnei Bivalent Conjugate Vaccine, Placebo)
Recruiting
- Dysentery
- Shigellosis
- S. Flexneriza-S. Sonnei Bivalent Conjugate Vaccine
- Placebo
-
Hezhou, Guangxi, China
- +8 more
Jan 6, 2022
Enterics for Global Health (EFGH)
Recruiting
- Shigella
- +2 more
-
Dhaka, Bangladesh
- +32 more
Sep 18, 2023
Shigella Trial in Baltimore (CVD 1208S, a Shigella flexneri 2a live, oral vaccine, Placebo)
Terminated
- Shigella
- CVD 1208S, a Shigella flexneri 2a live, oral vaccine
- Placebo
-
Baltimore, MarylandUniversity of Maryland, Baltimore Center for Vaccine Development
Apr 27, 2021
Shigellosis Trial in Baltimore (Flexyn2a, Placebo)
Completed
- Shigellosis
- Flexyn2a
- Placebo
-
Baltimore, MarylandJohns Hopkins Bloomberg School of Public Health, CIR
Jan 7, 2021
Shigella Trial in Baltimore (CVD 1208S, a Shigella flexneri 2a live, oral vaccine, Placebo)
Completed
- Shigella
- CVD 1208S, a Shigella flexneri 2a live, oral vaccine
- Placebo
-
Baltimore, Maryland
- +1 more
Apr 27, 2021
Shigella Trial in Baltimore (CVD 1208S, Challenge strain of wild-type Shigella flexneri 2a)
Terminated
- Shigella
- CVD 1208S, Challenge strain of wild-type Shigella flexneri 2a
-
Baltimore, Maryland
- +1 more
Apr 27, 2021
Shigellosis Trial in Baltimore (Vaccine: 2.6±0.8 x 10^8 vp/mL, 1 dose, Vaccine: 2.6±0.8 x 10^9 vp/mL, 3 doses, Vaccine: 2.6±0.8
Completed
- Shigellosis
- Vaccine: 2.6±0.8 x 10^8 vp/mL, 1 dose
- +4 more
-
Baltimore, Maryland
- +1 more
Aug 10, 2021
Dysentery, Bacillary Trial in Cincinnati (S.sonnei vaccine, Placebo, S. sonnei 53G challenge strain)
Completed
- Dysentery, Bacillary
- S.sonnei vaccine
- +2 more
-
Cincinnati, OhioGSK Investigational Site
Jul 16, 2020
Weight Gain, Anemia, Iron Deficiency, Birth Weight Trial in Mataram (Egg intervention)
Recruiting
- Weight Gain
- +16 more
- Egg intervention
-
Mataram, West Nusa Tenggara, IndonesiaAikmel, Sakra, and Sikur Subdistrict
Mar 17, 2021
Immunogenicity, Shigellosis Trial in Petach Tikva (Shigella Sonnei O-SPC/rBRU)
Completed
- Immunogenicity
- Shigellosis
- Shigella Sonnei O-SPC/rBRU
-
Petach Tikva, IsraelSchneider Children's Hospital
Dec 13, 2019
Dysentery, Bacillary Trial in Paris (GVGH Shigella sonnei 1790GAHB vaccine)
Completed
- Dysentery, Bacillary
- GVGH Shigella sonnei 1790GAHB vaccine
-
Paris, FranceGSK Investigational Site
Jun 13, 2019
Healthy Trial in Cincinnati (Shigella sonnei 53G)
Completed
- Healthy
- Shigella sonnei 53G
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Feb 21, 2019
Multidrug Resistant Shigella Infection in Bangladesh
Unknown status
- Diarrhea
- Shigella
-
Dhaka, BangladeshInternational Centre for Diarrhoeal Disease Research
Jan 25, 2019
Dysentery, Dysentery, Bacillary Trial in Yizhou (S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine)
Completed
- Dysentery
- Dysentery, Bacillary
- S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine
-
Yizhou, Guangxi, ChinaYizhou Center for Disease Control and Prevention
Oct 15, 2018